Applied DNA Sciences (APDN) Reports In-Line Q4 EPS, Miss on Revenues

Applied DNA Sciences (NASDAQ: APDN) reported Q4 EPS of ($0.10), in-line with the analyst estimate of ($0.10). Revenue for the quarter came in at $1.1 million versus the consensus estimate of $1.67 million.

For earnings history and earnings-related data on Applied DNA Sciences (APDN) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Stitch Fix (SFIX) Tops Q3 EPS by 4c, Offers Guidance
• Oracle (ORCL) Tops Q4 EPS by 16c, Offers Guidance